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INTRODUCTION
Cyclic adenosine 3′,5′-monophosphate (cAMP) is a critical intracellular signaling molecule that, in melanocytes, is robustly generated following interactions between the melanocortin 1 receptor (MC1R), a G s -coupled cell surface receptor, and alpha melanocyte stimulating hormone (MSH) (Beaumont et al., 2011; Palmer et al., 2000) . One of the most important inherited risk factors for UV skin sensitivity and development of melanoma is blunted MC1R-mediated cAMP signaling. Persons with loss-of-signaling MC1R polymorphisms (e.g. R151C, R160W and D294H) exhibit a fair-skinned sun-sensitive phenotype and have up to a four-fold increased lifetime risk of melanoma (Valverde et al., 1995) . A major route for channeling cAMP signaling is via cAMP-dependent protein kinase (PKA), an enzyme that influences a number of differentiation and survival pathways including biosynthesis of UV-protective melanin pigment (Lin and Fisher, 2007) . Though MC1R dysfunction is clearly linked with defective tanning (D'Orazio et al., 2006) , MC1R signaling also protects melanocytes against carcinogenesis independent of pigmentation (Abdel-Malek et al., 2009; Bohm et al., 2005; Hauser et al., 2006; Kadekaro et al., 2012) .
The mechanisms behind pigment-independent MC1R-mediated genome maintenance, however, remain unclear.
UV generates mutagenic DNA photolesions which if unrepaired lead to characteristic "UVsignature mutations" which are causative for melanoma (Hodis et al., 2012) . Photolesions engage the nucleotide excision repair (NER) pathway, which corrects UV-induced DNA damage in a multistep (DiGiovanna and Kraemer, 2012; Lehmann et al., 2011) . The importance of NER in resistance to UV-induced cancers is clearly demonstrated by observing the natural history of xeroderma pigmentosum (XP) patients, who through homozygous loss of one of the enzymes that carry out NER, are profoundly predisposed to melanoma and other UV-induced skin cancers (DiGiovanna and Kraemer, 2012) . Xeroderma pigmentosum complement group A (XPA), a gene frequently mutated in XP patients, is part of the core incision complex of NER and interacts with DNA as well as many other NER and damage response proteins (Bomgarden et al., 2006; Kang et al., 2011; Reardon and Sancar, 2005; Svetlova et al., 1999) . ATR (ATM and Rad3-related) is critical to UV DNA damage signaling (Ciccia and Elledge, 2010) and is intimately linked with NER (Bomgarden et al., 2006; Lindsey-Boltz et al., 2014) .
process involving numerous repair factors including XPA, ERCC1, ERCC3 (XP-B), XPC, ERCC2 (XP-D), DDB2 (XP-E), ERCC4 (XP-F) and ERCC5 (XP-G)
Herein, we report that a novel cAMP-dependent post-translational modification of ATR promotes its DNA-repair function, thus explaining how MC1R signaling is linked with NER. Specifically, PKA phosphorylates ATR at the Serine 435 (Ser435) position, causing enhanced physical interaction with XPA and accelerated binding to sites of DNA photodamage. PKA-mediated ATR phosphorylation reduces UVinduced mutagenesis, which is likely critical to how MC1R function protects melanocytes against malignant degeneration. Taken together, we report the molecular mechanism by which the MC1R-cAMP-PKA signaling axis enhances NER and reduces UV mutagenesis in melanocytes. Our findings highlight potential anti-mutagenic benefits of pharmacological cAMP stimulation in the skin of MC1R-deficient and melanoma-susceptible individuals.
RESULTS

MC1R Signaling Enhances Repair of UV-Induced Photolesions in vivo and in vitro
In order to determine the role of MC1R function and cAMP signaling in NER, we made use of a murine model of "humanized skin" in which epidermal melanocytes are retained in the skin (D'Orazio et al., 2006; Spry et al., 2009) . K14-Scf transgenic animals congenic except for function at the Mc1r or tyrosinase (tyr) loci ( Figure 1A ) were irradiated with UV to ascertain pigment-independent effects of Mc1r on DNA repair (D'Orazio et al., 2006; Vanover et al., 2009 ). Clearance of UV-induced cyclobutane pyrimidine dimers (CPD) was impaired in animals expressing inactive Mc1r (Mc1r e/e ) when compared to those with wild type Mc1r, as measured by time taken to repair 50% of UV damage (repair t 1/2 for CPD removal 42 ± 6.3 h vs. 24 ± 0.7 h respectively; p ≤ 0.05) ( Figure 1B ). We reasoned that since Mc1r
e/e mice lacked the ability to generate cAMP in response to MSH, cutaneous application of forskolin, a skinpermeable adenylyl cyclase activator would restore DNA repair of UV photodamage. Topically-applied 5 forskolin robustly enhanced clearance of UV photodamage in the skin, essentially to Mc1r wild type levels (repair t 1/2 23 ± 2.7 h vs. 44 ± 3.3 h in treated vs. untreated animals respectively; p ≤ 0.05; Figure   1C ). Importantly, neither Mc1r status nor forskolin application influenced initial amount of UV-induced DNA damage (Figures S1A and S1B) . Since measuring repair in murine whole skin represents the combined influence of numerous cell types, we repeated photolesion clearance studies in B16
immortalized mouse melanocytes. Pre-treatment of B16 cells (Mc1r
E/E
) with either MSH (MC1R agonist), forskolin or the phosphodiesterase inhibitor rolipram enhanced removal of CPDs compared to vehicletreated cells ( Figure 1D ), again without affecting amount of initial UV damage ( Figures S1C and S1D ).
Thus, Mc1r signaling or pharmacologic stimulation of cAMP optimized melanocytic NER in murine whole skin and in a melanocyte cell line.
cAMP Signaling Enhances DNA Repair in Human Cells
To determine whether cAMP-mediated NER enhancement extended to human cells, we measured the Table 1 ). Addition of agouti signaling protein (ASIP), a potent MC1R antagonist (Lu et al., 1994) , abrogated any MSH-mediated repair benefit (Supplemental Table 1 ). The MC1R-defective melanoma cell line A375 exhibited slower repair of UV damage compared to MC1R-wild type cells and had a markedly blunted response to MSH (Supplemental Table   1 ). However, forskolin enhanced clearance of both [6-4]-PP and CPD in all melanocyte cells tested regardless of MC1R status (Figures 1E and 1F) with no apparent effect on cell proliferation ( Figure S2) indicating photolesion clearance was not influenced by proliferative differences. Furthermore, UV damage alone did not promote production of cAMP ( Figure S2E ), suggesting that in the skin UVassociated melanocytic cAMP increases depend on an intact MC1R signaling pathway initiated by MSH.
Interestingly, cAMP-enhanced repair was not limited to melanocytic lines, as a repair benefit was also observed in .
6
To confirm the specificity and importance of MC1R in melanocytic NER, complementation studies were performed in MC1R-mutant (R151C) A375 melanoma cells. MSH pre-treatment enhanced repair of [6-4]-PP and CPDs when cells were transfected with wild-type MC1R but not when cells were transfected with MC1R mutants (either R151C, R160W or D294H) ( Figure 1G and H). Together, these data strongly support an integral role for MC1R/cAMP signaling in UV repair responses and support the hypothesis that pharmacologic induction of cAMP signaling enhances NER.
Recruitment of XPA to UV-Induced Photolesions is Enhanced by cAMP Signaling
cAMP stimulation failed to increase total protein levels of core NER factors ( Figure S3A ), however we explored whether distribution of key NER proteins to sites of UV-induced DNA damage might be affected. We found that cAMP signaling influenced kinetics of XPA nuclear accumulation and recruitment to chromatin after UV-induced DNA damage (Figures 2A, 2B and 2C) . and S3E), whereas addition of ASIP, a potent MC1R antagonist that down-regulates cAMP signaling, abrogated MSH-mediated benefit, confirming the importance of XPA and MC1R in the repair of UVinduced DNA damage. Interestingly, DNA-bound XPA was enhanced by forskolin even in the absence of UV, suggesting that cAMP stimulation might somehow enhance XPA-chromatin interactions before 7 UV damage occurs. We conclude that cAMP signaling enhances and directs accumulation of XPA to chromatin and sites of UV damage and that pharmacologic induction of cAMP "rescues" NER in MC1R-mutant melanocytes otherwise incapable of responding to MSH.
cAMP-Mediated Signaling Facilitates XPA-ATR Interaction
To gain further insight into how MC1R signaling affects XPA-chromatin association and NER enhancement, we tested whether cAMP signaling enhanced the ability of XPA to bind DNA repairrelevant proteins in a UV-dependent manner. A proteomic screen of XPA-immunoprecipitated lysates revealed that cAMP-mediated signaling enriched XPA-associated ATR by at least two-fold. Since prior work by others suggested that ATR influenced NER in other cell types (Shell et al., 2009; Wu et al., 2007; Wu et al., 2006) , we hypothesized that cAMP enhances NER in melanocytes by promoting biochemical interaction between ATR and XPA. Co-immunoprecipitation experiments confirmed that cAMP stimulation promoted a robust and accelerated physical interaction between ATR and XPA in UVradiated A375 melanoma cells, as detected either in whole cell lysates ( Figure 3A ) or with chromatin ( Figure 3B ).
To confirm the importance of the cAMP-dependent ATR-XPA interaction to NER in melanocytes, A375 cells were transfected with small interfering RNA (siRNA) targeting ATR. ATR knockdown greatly reduced baseline and forskolin-mediated recruitment of XPA to UV-damaged chromatin (~2.0-fold decrease; p ≤ 0.05) ( Figure 3C ), blocked forskolin-mediated NER enhancement ( Figure 3D ) and blunted repair of UV-induced [6-4]-PP (repair t ½ 4.5 ± 0.4 h vs. 2.9 h ± 0.2 h in scrambled siRNA-transfected cells; p ≤ 0.05) ( Figure 3D ). These data suggest that cAMP-mediated NER enhancement results from accelerated and increased association of an ATR-XPA complex with UVdamaged DNA and that ATR is critical in mediating MC1R optimization of melanocytic NER.
ATR signals through multiple pathways to promote genome maintenance. Most typically, cell damage leads to ATR phosphorylation and activation of the ATR-Chk1 pathway which promotes G 2 /M 8 cell cycle arrest (Cortez et al., 2001; Liu et al., 2000) . We tested whether cAMP-mediated ATR phosphorylation on Ser435 promoted Chk1 phosphorylation and cell cycle arrest in melanocytes.
Whereas UV exposure led to robust Chk1 phosphorylation, forskolin treatment had no effect on total Chk1 levels or phospho-Chk1 levels ( Figure 3E ). Similarly, exposing A375 melanocytes to UV promoted a G 2 /M cell cycle arrest, whereas forskolin treatment had no effect on the cell cycle ( Figure 3F ), suggesting that cAMP-induced ATR phosphorylation is a distinct form of ATR signaling independent of Chk1 phosphorylation and cell cycle arrest.
MC1R/cAMP Signaling Suppresses UV-Induced Mutagenesis in an XPA/ATR-Dependent Process
Since cAMP signaling enhanced clearance of UV-dependent photolesions, we reasoned that cAMP signaling would protect melanocytes against UV-induced mutagenesis. To test this, we performed hypoxanthine phosphoribosyltransferase (hprt) mutagenesis screens on a variety of melanocyte cell lines with or without cAMP stimulation. UV exposure resulted in mutant colony formation in all cell lines ( Figure 4A ), with similar mutation frequencies to other hprt mutagenesis studies (Wigan et al., 2012) .
MC1R mutant cell lines exhibited higher mutation rates when compared to MC1R wild-type cells. Pretreatment of cells with MSH reduced UV-induced mutagenesis in MC1R wild type cells but failed to affect mutation rates in MC1R mutant lines ( Figure 4A ). In contrast, forskolin pre-treatment suppressed UV-induced mutagenesis in every cell line tested, irrespective of MC1R status. In the absence of UV, no mutant colonies were observed regardless of MC1R status. We concluded from these observations that cAMP-signaling results in an increased ability of melanocytes to resist UV-induced mutagenesis.
We next explored the need for a physical ATR-XPA interaction on cAMP-mediated protection against UV-induced mutagenesis. To do so, we compared UV responses of XPA-null fibroblasts expressing either mutant XPA (K188A) lacking the ability to bind ATR (Shell et al., 2009) Figure 4C ), indicating that cAMP-mediated XPA translocation to chromatin and resultant protection from UV mutagenesis is dependent on a physical ATR-XPA interaction.
PKA promotes ATR phosphorylation and its interaction with XPA
Computer motif analysis predicted that ATR possesses a single PKA phosphorylation consensus sequence on Serine 435 (Ser435; RX(p)SX). Phosphorylation of Ser435 on ATR has been previously reported , however, the kinase responsible for phosphorylating this residue as well as its functional relevance is unknown. We reasoned that cAMP-mediated recruitment of XPA to sites of UVinduced DNA damage would be mediated by PKA-mediated phosphorylation of ATR. Coimmunoprecipitation experiments using a PKA phosphorylation-specific substrate antibody (p-PKA), revealed forskolin treatment increased ATR phosphorylation, and that this phosphorylation was ablated in the presence of the specific PKA inhibitor, H-89 ( Figure 5A ). We posited that cAMP directs PKAmediated phosphorylation of Ser435 on ATR to promote interaction with XPA and accumulation at sites of DNA damage. To test this, a site-specific mutant of ATR was engineered containing an alanine substitution at the 435 position (S435A), which completely abolished forskolin-mediated PKA phosphorylation of ATR ( Figure 5B ). Furthermore, an ATR Ser435 phosphopeptide-specific antibody (p-S435) was generated that recognizes ATR only when phosphorylated specifically at Ser435 ( Figure S4A , S4B and S4C). Forskolin pre-treatment increased phosphorylation of Ser435 on ATR following UV exposure (~2-fold induction compared to vehicle treated cells; p ≤ 0.05) and phosphorylation at this site was ablated in the presence of the specific PKA inhibitor, H-89 ( Figure 5C ). In addition, forskolin pretreatment increased the interaction between phosphorylated Ser435 ATR and XPA following UV damage in whole cell lysates (Figures 5D), suggesting that PKA-mediated Ser435 phosphorylation facilitates ATR's physical interaction with XPA. Intriguingly, Ser435 in the context of a consensus PKA phosphorylation target sequence (RRX(p)S) appears to be conserved among vertebrates suggesting widespread physiological relevance of the PKA-ATR interaction ( Figure 5E ).
PKA Directly Phosphorylates ATR at Serine 435
To further characterize PKA-mediated phosphorylation of ATR, in vitro phosphorylation experiments were performed. Nuclear extracts isolated from ATR hypomorphic Seckel cell-lymphocytes were transfected with either wild-type or Ser435-mutant ATR (S435A) and incubated with recombinant catalytically active PKA. Phosphorylation of wild-type but not S435A-mutant ATR was identified and the reaction was blocked by the specific PKA inhibitor H-89 ( Figure 6A ). To address whether ATR is a direct substrate for PKA, we tested PKA's ability to phosphorylate a short ATR peptide containing Ser435 and surrounding residues in a cell-free system. Whereas PKA promoted robust phosphorylation of the wild type ATR peptide containing S435, there was no phosphorylation of the S435A mutant form ( Figure 6B ). Enzyme kinetic studies of PKA activity revealed similar K m values for wild-type ATR compared with other known PKA substrates ( Figure 6C ). Notably, ATR S435A was not phosphorylated by recombinant catalytically active PKA ( Figure 6C ). The specificity and importance of MC1R in PKAmediated ATR phosphorylation was confirmed in human embryonic kidney (HEK) cells. Thus, MSH pretreatment enhanced ATR phosphorylation on Ser435 in HEK 293 cells transfected with wild-type MC1R but had no effect when cells were instead transfected with loss-of-function MC1R mutants ( Figure 6D ).
We tested the functional consequences of PKA-mediated ATR phosphorylation on NER by measuring clearance of UV photodamage. Recombinant catalytically active PKA enhanced NER in ATRhypomorphic Seckel lymphocytes transfected with wild type (S435) but not mutant (S435A) ATR ( Figure   6E ). Further, PKA enhanced NER in a variety of cell types ( Figure 6F ), suggesting that cAMP-directed PKA activation may also influence NER in non-melanocytic cells. Despite promoting NER, it appears that S435 ATR phosphorylation has little impact on global UV sensitivity ( Figure S4D ). Together, these data identify that the Ser435 residue is a direct target of PKA and that its phosphorylation specifically enhances repair of UV-induced DNA damage. (Cao et al., 2013) , MC1R signaling also protects melanocytes against carcinogenesis independent of pigmentation (Hauser et al., 2006) . Mediated by robust cAMP second messenger generation, MC1R signaling enhances the rate of clearance of UVinduced DNA photodamage Dong et al., 2010; Kadekaro et al., 2012) . Herein, we report that MC1R signaling enhances NER by a novel and direct PKA-mediated phosphorylation of ATR on Ser435. This is the first report of a post-translational modification of ATR promoting a DNArepair specific function and the first to mechanistically link PKA to MC1R signaling and the genomic maintenance pathway responsible for clearance of UV-induced photolesions known to be causal for melanoma. Ser435 phosphorylation by PKA promotes ATR's physical association with XPA and directs XPA to sites of UV damage in the nucleus to accelerate repair of photodamage and protect against UVinduced mutagenesis. Although studies in other systems demonstrate UV-dependent ATR-XPA interactions (Dong et al., 2010; Shell et al., 2009; Wu et al., 2007) , our data mechanistically link ATR and
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XPA with the MSH-MC1R-cAMP signaling axis, and experiments using the phosphomimetic S435D ATR mutant suggest that Ser435 phosphorylation is both necessary and sufficient for ATR to mediate MC1R-enhanced NER.
PKA-induced phosphorylation of ATR is distinct from the ATR-Chk1 pathway (Cortez et al., 2001; Liu et al., 2000) since phosphorylation of Ser435 does not promote Chk1 phosphorylation or cell cycle arrest, as was described for other ATR phosphorylation events (e.g. Ser435, Ser428, Ser436 and Ser437) (Daub et al., 2008; Dephoure et al., 2008; Liu et al., 2011; Nam et al., 2011) . Instead, phosphorylation of Ser435 promotes NER independent of traditional damage signaling coordinated by ATR. PKA-mediated phosphorylation of other genome maintenance proteins have recently been reported (Marazita et al., 2012; Rahmeh et al., 2012) , suggesting cAMP signaling may be an important event acting to globally prime DNA repair.
Ser435 is part of a PKA target sequence (RRXS*) within ATR's predicted nuclear localization sequence (425-DGISPKRRRLSSSLNPSKRAP), suggesting that its phosphorylation might impact ATR's nuclear localization, possibly through interactions with nuclear importins (Li et al., 2013) . Indeed, colocalization studies of phosphoSer435 ATR and XPA suggest that PKA modification promotes nuclear entry of ATR-XPA to prime NER for DNA damage. PKA-directed nuclear localization of DNA-PK, another PIKK family member, has also been reported (Huston et al., 2008) . Alternatively, PKA-mediated phosphorylation of ATR at Ser435 may optimize NER through enhanced intra-nuclear interactions with XPA to aid transport and/or assembly at sites of UV damage using either enzymatic and/or non-enzymatic mechanism(s). It is possible that the phospho-Ser435 ATR-XPA complex recognizes UV damaged sites through RPA binding (Zou and Elledge, 2003) or perhaps via the excision gap generated by NER (Lindsey-Boltz et al., 2014) . In any case, our findings suggest that PKA-mediated phosphorylation of ATR at Ser435 is an important event that dynamically regulates early recruitment/assembly of XPA and possibly other DNA repair proteins to sites of UV damage to optimize NER. (Shell et al., 2009; Wu et al., 2007; Wu et al., 2006) , wild-type ATR (Jiang and Sancar, 2006) or mutated ATR (S435A and S435D; constructed using the QuikChange site-directed mutagenesis kit (Stratagene, CA)), pDONR221 vector containing either wild-type MC1R (DNASU Plasmid Repository) or mutated MC1R (R160W and D294H; constructed using the QuikChange site-directed mutagenesis kit (Stratagene, CA)) were cultivated using standard procedures. siRNA targeted to ATR (Dharmacon) was performed using manufacturer's instructions. UV at a dose of 10 J/m 2 (unless otherwise indicated) was delivered to cell cultures with lamps emitting either in UVB or UVC range.
Antibodies
The phopsho-specific antibody (p-S435) was generated by Amsbio against the peptide 
DNA Repair Kinetics and Mutagenesis
Immuno-slot-blots were performed on whole cells and nuclear extracts using either [6-4]-PP or CPD antibodies using standard methods (Mellon et al., 2002) . All doses of UV for repair studies were 10 J/cm 2 unless stated otherwise. Acquired resistance of cells to 6-thioguanine (6-TG) is conferred primarily by mutations within the hprt locus and quantified as mutation frequency after selection. Frequencies of UVinduced hprt mutations were measured as previously described (Glaab and Tindall, 1997) .
Chromatin Isolation, Immunoprecipitation and Immunoblotting
Chromatin isolation was performed essentially as previously described (Zou et al., 2002) . Briefly, 5 × 10 6 cells were washed with PBS and resuspended in Solution A (10 mM HEPES at pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.34 M sucrose, 10% glycerol, 1 mM DTT, with protease and phosphatase inhibitors freshly added (Thermo Scientific)). Cells were lysed with 0.5 % Triton X-100 incubated for 5 min at 4 o C, following which, nuclear proteins were pelleted by centrifugation at 1300 g for 5 min pelleted and washed with solution A and lysed in 400 μL of solution B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT) for 10 min at 4 o C and centrifuged at 15000 g for 3 min. The chromatin was sheared by sonication and digested with micrococcal nuclease (50 units) and proteins resuspended in solution A.
Immunoprecipitations were performed overnight at 4 o C using 5 μg of antibody and protein G agaraose, washed 5 times with RIPA buffer and separated by SDS-PAGE prior immunoblotting. All immunoblotting was performed using ECL and quantified using the STORM system.
In Vitro Kinase Assays
PKA kinase assays were carried out in a similar fashion to previous reports (Bondzi et al., 2000) . Briefly, 30 μM of peptide (either custom ATR peptides; CPKRRRLSSSLNPS or CPKRRRLASSLNPS or commercially available PKA-substrate peptides; Kemptide, CREBtide, BCL-2 and H1-7 (Santa-Cruz)
were used as substrates together with 40 mM Tris-Cl (pH 7.5), 10 mM MgCl 2 , 1 mM DTT, 100 μg/mL BSA and 10 μM ATP. Reactions were either initiated by the addition of 10 nM recombinant catalytic subunit of PKA enzyme (Invitrogen) or whole cell lysate, carried out at 30 o C and stopped by the addition of 10 μL of 100 mM EDTA. The extent of PKA phosphorylation was measured by immune-slot-blots using either anti-pS435 or anti-PKA substrate antibody (Cell Signalling). Detection was accomplished using ECL and quantified using the STORM system. Equal loading of PKA and substrate peptides was 17 confirmed by SYPRO Ruby staining (Invitrogen). The kinetic parameters of the phosphorylation reaction were calculated by non-linear regression analysis using Graphpad Prism.
Immunofluorescence and Proximity Ligand Assay (PLA)
To achieve localized UV irradiation, melanoma cells were grown on plastic chamber slides (Lab-Tek), media was aspirated, and UVC (50 J/m 2 ) applied through sterile UV-absorbing polycarbonate with 3-μm pores (Millipore). The membrane was removed and cells were either processed immediately, or medium was replaced and DNA repair 30 minutes. Cell extraction was carried out in situ by 2 washes of 0.05% Nonidet P-40 followed by fixation in 4% paraformaldehyde. Antibodies directed to XPA (Abcam), PP (Cosmo. Bio.) and secondary antibodies conjugated to DyLight Fluors (DyLight 549 and 488; Jackson ImmunoResearch) were used for immunodetection. PLA assay (DuoLink) was performed on 16 well chamber slides (Lab-Tek) and exposed to UV (10 J/m 2 ). After antibodies were incubated overnight, fluorescence probes were used to visualize close proximity protein interactions as previously described (Soderberg et al., 2006) . All fluorescence images were obtained using a Leica SP5 inverted confocal laser scanning microscope.
BrdU/PI staining for cell cycle
Sub-confluent A375 cells were treated with 5-bromo-2'-deoxyuridine (BrdU)/thymidine at final concentrations of 20 μM using standard procedures for anti-BrdU-fluorescence-based flow cytometry. (C) A375 cells were pre-treated with forskolin (20 μM), exposed to UV (10 J/m 2 ) and total levels of phosphorylated Ser435 were determined at 0, 0.5 and 2 h post-UV exposure in whole cell extracts using an antibody specific to phosphorylated S435 (p-S435).
Statistical Analysis
(D) Co-immunoprecipitation experiments using A375 whole cell extracts with either an anti-phosphoSer435 (p-S435) or anti-XPA, immunoblotted reciprocally after vehicle or forskolin (20 μM) pretreatment. Cells were either mock-treated or exposed to UV (10 J/m 2 ). Input 10% of total lysate.
(E) Sequence alignment of ATR orthologous at Serine 435 and surrounding residues among vertebrates.
Red-shaded boxes show the conserved Serine, black-shaded boxes indicate conserved residues and yellow boxes denote residues with similar characteristics. (C) Direct PKA kinase assays were carried out using 30 μM of indicated peptide (all containing a PKA phosphorylation site) as substrates together with recombinant PKA (10 nM) and ATP (20 μM) for 10 min.
The extent of phosphorylation at Ser435 was measured by immune-slot-blot using anti-PKA-substrate
antibody. The kinetic parameters of the phosphorylation reaction were calculated by non-linear regression analysis.
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(D) HEK293 cells (MC1R null) were transfected with either wild-type MC1R or mutant MC1R (R160W or D294H) and pre-treated with MSH for 30 min. Whole cell lysates were incubated with 30 μM peptide (CPKRRRLSSSLNPS) as a substrate for 10 min. The extent of phosphorylation at Ser435 was measured by immune-slot-blot using anti-pS435. The kinetic parameters of the phosphorylation reaction were calculated by non-linear regression analysis.
(E) Seckel cell-lymphocytes were either transfected with wild-type FLAG expressing ATR (ATR-WT) or FLAG expressing mutant ATR (S435A) and exposed to UV (10 J/m 2 ). Recombinant PKA was incubated with nuclear extracts for either 0, 1 or 3 h post UV exposure and [6-4]-PP removal was determined using immune-slot-blot using anti-pS435.
(F) Human cell lines (A375, MCF-7 and ARPE-19) were exposed to UV (10 J/m 2 ) and recombinant PKA (either 1, 100 or 500 nM) incubated with nuclear extracts and DNA repair measured using anti-[6-4]-PP immunoblotting at either 0, 1 or 3 h post UV exposure. Graph shows linear regression analysis of time taken to repair 50% of initial damage (repair t ½ (h)) correlated with the amount of recombinant PKA added to nuclear extract (i.e. 1, 100 or 500 nM). M e l a n o c y t e s M e l a n o c y t e s S K -M E L -2 A 3 7 5 M C F -7 A R P E -1 9 ( l i g h t p i g m e n t ) ( h e a v y p i g m e n t ) M e l a n o c y t e s M e l a n o c y t e s S K -M E L -2 A 3 7 5 M C F -7 A R P E -1 9 ( l i g h t p i g m e n t ) ( h e a v y p i g m e n t ) * * * Immunofluorescence and confocal microscopy were carried out to determine the effect of cAMP on cytoplasmic/nuclear distribution of ATR, ATR-pS435 and XPA. Cells were pre-treated with either forskolin (20 M) or vehicle and the cytoplasmic/nuclear ratio of each protein was determined. All fluorescence images were obtained using a Leica SP5 inverted confocal laser scanning microscope and analyzed as inverted grey scale images. Data were considered statistically significant if p values were less than 0.05. 
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